FDA Inspection 732158 — Murty Pharmaceuticals, Inc
The FDA completed an inspection of Murty Pharmaceuticals, Inc on June 22, 2011 in Lexington, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 22, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lexington, KY (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)